Artículos publicados por profesionales del H12O del 14 al 20 de marzo

Relación de artículos recogidos por PubMed entre el 14 y el 20 de marzo, cuyos primeros autores son profesionales del  Hospital 12 de Octubre:

Bengoa-González Á, Lago-Llinás MD, Mencía-Gutiérrez E, Martín-Clavijo A, Salvador E, Gimeno-Carrero M. Surgical removal of orbital tumors by orbital approach using ultrasonic surgical system SONOPET®. Orbit. 2022 Apr;41(2):216-225. Disponible en: https://doi.org/10.1080/01676830.2021.1912115

Calleja-García C, Muñoz-Gallego A, Dorado-López-Rosado A, López-López C, Tejada-Palacios P. Ophthalmological manifestations in 6 patients diagnosed with Williams-Beuren syndrome and literature review. Arch Soc Esp Oftalmol (Engl Ed). 2022 Mar 12:S2173-5794(22)00047-0. Disponible en: https://doi.org/10.1016/j.oftale.2022.03.

Corbella L, Boán J, San-Juan R, Fernández-Ruiz M, Carretero O, Lora D, et al. Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa. Int J Antimicrob Agents. 2022 Feb;59(2):106517. Disponible en: https://doi.org/10.1016/j.ijantimicag.2021.106517.

Domínguez-González C, Fernández-Torrón R, Moore U, De Fuenmayor-Fernández de la Hoz CP, Vélez-Gómez B, Cabezas JA, et al. Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis. J Neurol. 2022 Mar 14. Disponbible en: https://doi.org/10.1007/s00415-021-10957-0.

La Salvia A, Persano I, Siciliani A, Verrico M, Bassi M, Modica R, et al. Prognostic significance of laterality in lung neuroendocrine tumors. Endocrine. 2022 Mar 18. Disponible en: https://doi.org/10.1007/s12020-022-03015-w.

Luna-López R, Ruiz Martín A, Escribano Subías P. Pulmonary arterial hypertension. Med Clin (Barc). 2022 Mar 9:S0025-7753(22)00002-1. Disponible en: https://doi.org/10.1016/j.medcli.2022.01.003.

Martínez-Maldonado A, Verdejo-Román J, Sion A, Rubio G, Pérez-García M, Jurado-Barba R. Effect of chronic alcohol consumption on brain structure in males with alcohol use disorder without a familiar history of alcoholism. J Psychiatr Res. 2022 Mar 8;149:210-216. Disponible en: https://doi.org/10.1016/j.jpsychires.2022.03.005.

Moya B, Barranco R, García-Moguel I, Puerta-Peña M, Alonso L, Fernández-Crespo J. First confirmed case of nonimmediate hypersensitivity to fremanezumab during chronic migraine treatment. Contact Dermatitis. 2022 Apr;86(4):308-310. Disponible en: https://doi.org/10.1111/cod.14018.

Origüen J, Caro-Teller JM, López-Medrano F. Early Treatment with Sotrovimab for Covid-19. N Engl J Med. 2022 Mar 16:10.1056/NEJMc2201606#sa2. Disponible en: https://doi.org/10.1056/NEJMc2201606.

Paz-Ares L, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, et al. Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN. ESMO Open. 2022 Mar 10;7(2):100408. Disponible en: https://doi.org/10.1016/j.esmoop.2022.100408.

San-Juan R, Aguado JM. Pre-emptive approach against toxoplasmosis in allogeneic haematopoietic cell transplantation. Still far away from experience in CMV. Clin Microbiol Infect. 2022 Mar;28(3):319-320. Disponible en: http://doi.org/10.1016/j.cmi.2021.11.018.

Equipo H12O